Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avexitide in Acquired Hyperinsulinemic Hypoglycemia
NCT04652479Phase 2Completed
- Start
- Jun 2021
- Primary completion
- Jun 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exendin 9-39 in acquired hyperinsulinemic hypoglycemia. Started Jun 2021; status: completed.
02
Drugs
exendin 9-39
03
Conditions
acquired hyperinsulinemic hypoglycemia
Beyond the preview
Go deeper on NCT04652479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04652479.